These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 32270376)

  • 41. [ COVID-19 scenario and initiatives under development].
    Pavan JV; Depetris A; Nates SV
    Rev Fac Cien Med Univ Nac Cordoba; 2020 May; 77(2):59-60. PubMed ID: 32558505
    [No Abstract]   [Full Text] [Related]  

  • 42. Stemming the flow: how much can the Australian smartphone app help to control COVID-19?
    Currie DJ; Peng CQ; Lyle DM; Jameson BA; Frommer MS
    Public Health Res Pract; 2020 Jun; 30(2):. PubMed ID: 32601652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hospital care in Departments defined as COVID-free: A proposal for a safe hospitalization protecting healthcare professionals and patients not affected by COVID-19.
    Leonardi R; Bellinzoni P; Broglia L; Colombo R; De Marchi D; Falcone L; Giusti G; Grasso V; Mantica G; Passaretti G; Proietti S; Russo A; Saitta G; Smelzo S; Suardi N; Gaboardi F
    Arch Ital Urol Androl; 2020 Apr; 92(2):. PubMed ID: 32597101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Czech Republic and low COVID-19 mortality in the heart of Europe: possible explanations.
    Widimsky P; Benes J; Celko AM
    Eur Heart J; 2020 Oct; 41(40):3876-3879. PubMed ID: 33170931
    [No Abstract]   [Full Text] [Related]  

  • 45. Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland.
    Lemaitre JC; Perez-Saez J; Azman AS; Rinaldo A; Fellay J
    Swiss Med Wkly; 2020 May; 150():w20295. PubMed ID: 32472939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronavirus disease 2019 outbreak.
    Patrucco F; Gavelli F; Shi R; De Vita N; Pavot A; Castello LM; Ravanini P; Balbo PE
    Panminerva Med; 2020 Jun; 62(2):73-74. PubMed ID: 32208412
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 observations and accompanying dataset of non-pharmaceutical interventions across U.S. universities, March 2020.
    Cevasco KE; North HM; Zeitoun SA; Wofford RN; Matulis GA; Gregory AF; Hassan MH; Abdo AD; Farris D; Roess AA; von Fricken ME
    PLoS One; 2020; 15(10):e0240786. PubMed ID: 33064753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of the Emergency Services Swab Resource Team During COVID-19.
    Hamm R; Komansky B; Beck E
    J Nurses Prof Dev; 2020; 36(5):317. PubMed ID: 32890192
    [No Abstract]   [Full Text] [Related]  

  • 49. COVID-19 in a Sydney nursing home: a case study and lessons learnt.
    Gilbert GL
    Med J Aust; 2020 Nov; 213(9):393-396.e1. PubMed ID: 33037646
    [No Abstract]   [Full Text] [Related]  

  • 50. Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown.
    Goscé L; Phillips PA; Spinola P; Gupta DRK; Abubakar PI
    J Infect; 2020 Aug; 81(2):260-265. PubMed ID: 32461062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significant relaxation of SARS-CoV-2-targeted non-pharmaceutical interventions may result in profound mortality: A New York state modelling study.
    Hoffman BU
    PLoS One; 2020; 15(9):e0239647. PubMed ID: 32970745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A dynamic modeling tool for estimating healthcare demand from the COVID19 epidemic and evaluating population-wide interventions.
    Rainisch G; Undurraga EA; Chowell G
    Int J Infect Dis; 2020 Jul; 96():376-383. PubMed ID: 32425631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing the impact of adherence to Non-pharmaceutical interventions and indirect transmission on the dynamics of COVID-19: a mathematical modelling study.
    Iyaniwura SA; Rabiu M; David JF; Kong JD
    Math Biosci Eng; 2021 Oct; 18(6):8905-8932. PubMed ID: 34814328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ranking the effectiveness of worldwide COVID-19 government interventions.
    Haug N; Geyrhofer L; Londei A; Dervic E; Desvars-Larrive A; Loreto V; Pinior B; Thurner S; Klimek P
    Nat Hum Behav; 2020 Dec; 4(12):1303-1312. PubMed ID: 33199859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect estimates of COVID-19 non-pharmaceutical interventions are non-robust and highly model-dependent.
    Chin V; Ioannidis JPA; Tanner MA; Cripps S
    J Clin Epidemiol; 2021 Aug; 136():96-132. PubMed ID: 33781862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Modeling the effect of non-pharmaceutical interventions during the corona pandemic].
    Gustafsson F; Timpka T
    Lakartidningen; 2021 May; 118():. PubMed ID: 34014556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxygen supplies and COVID-19 mortality in Africa.
    Nakkazi E
    Lancet Respir Med; 2021 Apr; 9(4):e39. PubMed ID: 33581079
    [No Abstract]   [Full Text] [Related]  

  • 58. The Tipping Effect of Delayed Interventions on the Evolution of COVID-19 Incidence.
    Rypdal K
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33922564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. International comparisons of COVID-19 case and mortality data and the effectiveness of non-pharmaceutical interventions: a plea for reconsideration.
    Thomson S; Ip EC; Lee SF
    J Biosoc Sci; 2022 Sep; 54(5):735-741. PubMed ID: 34702386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Projecting the effect of easing societal restrictions on non-COVID-19 emergency demand in the UK: Statistical inference using public mobility data.
    Powell AL; Wood RM
    Int J Health Plann Manage; 2021 Sep; 36(5):1936-1942. PubMed ID: 34212400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.